← Back to directory

Alexandros D. Tselepis

Researcher Next ID · RN-026943

Researcher · Medicine

University of Ioannina

Ioannina, Greece

Not currently recruitingFunding unknown
Works count
347
Citation count
18,904
H-index
52
i10-index
198

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Lipoproteins and Cardiovascular Health
Antiplatelet Therapy and Cardiovascular Diseases
Diabetes, Cardiovascular Risks, and Lipoproteins
Cancer, Lipids, and Metabolism
Platelet Disorders and Treatments

Publications

  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

    European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz455

  • The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis

    Atherosclerosis · 2019 · https://doi.org/10.1016/j.atherosclerosis.2019.06.919

  • The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement

    Metabolism · 2017 · https://doi.org/10.1016/j.metabol.2017.02.014

  • “European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

    Current Vascular Pharmacology · 2011 · https://doi.org/10.2174/157016111796642661

  • Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma

    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2009 · https://doi.org/10.1016/j.bbalip.2009.02.015

  • New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A 2 in Atherosclerosis and Cardiovascular Disease

    Arteriosclerosis Thrombosis and Vascular Biology · 2007 · https://doi.org/10.1161/01.atv.0000280571.28102.d4

  • Oxidative Stress Is Progressively Enhanced With Advancing Stages of CKD

    American Journal of Kidney Diseases · 2006 · https://doi.org/10.1053/j.ajkd.2006.08.015

  • Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment – a prospective, controlled study

    Arthritis Research & Therapy · 2006 · https://doi.org/10.1186/ar1952

  • Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human Plasma

    Clinical Chemistry · 2005 · https://doi.org/10.1373/clinchem.2005.058404

  • Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase

    Atherosclerosis Supplements · 2002 · https://doi.org/10.1016/s1567-5688(02)00045-4

  • Atorvastatin Preferentially Reduces LDL-Associated Platelet-Activating Factor Acetylhydrolase Activity in Dyslipidemias of Type IIA and Type IIB

    Arteriosclerosis Thrombosis and Vascular Biology · 2002 · https://doi.org/10.1161/hq0202.102918

  • Laparoscopic surgery-induced changes in oxidative stress markers in human plasma

    Surgical Endoscopy · 2001 · https://doi.org/10.1007/s00464-001-0034-2

  • PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human Plasma

    Arteriosclerosis Thrombosis and Vascular Biology · 1995 · https://doi.org/10.1161/01.atv.15.10.1764

Current projects

    No projects listed.